Lipotype GmbH
![Kai_Simons Kai_Simons](https://h2020-remedia.eu/wp-content/uploads/2021/05/Kai_Simons-100x100.png)
Kai Simmons
Founder and CEO
WP2 contributor
![Julia_Froebel Julia_Froebel](https://h2020-remedia.eu/wp-content/uploads/2021/05/Julia_Froebel-100x100.png)
Julia Fröbel
Scientific Project Manager
WP2 contributor
![Oliver_Uecke Oliver_Uecke](https://h2020-remedia.eu/wp-content/uploads/2021/05/Oliver_Uecke-100x100.png)
Oliver Uecke
COO
WP2 contributor
![Christian_Klose Christian_Klose](https://h2020-remedia.eu/wp-content/uploads/2021/05/Christian_Klose-100x100.png)
Oliver Uecke
CTO
WP2 contributor
Lipotype is a leading lipidomics provider and delivers comprehensive, absolutely quantitative lipid analysis services for clinical and biological samples on a high-throughput scale. Drawing on many years of cutting-edge research experience, Lipotype offers high quality lipid analysis services for a wide range of customers and applications including tissue and blood lipidomes, biomarker identification for clinical researchers, pharma and biotech companies as well as for the small-scale profiling needs of academic researchers. Lipotype is a spin-off company from the Kai Simons and Andrej Shevchenko labs of the Max-Planck-Institute of Molecular Cell Biology and Genetics in Dresden, Germany.